Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 30.01.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 367,80 270 | 367,80 | 270 | 26,590538 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 367,80 350 | 367,80 | 350 | 4,839587 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 367,80 350 | 367,80 | 350 | 4,839587 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 367,80 360 | 367,80 | 360 | 2,120718 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 367,80 390 | 367,80 | 390 | 6,035889 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 367,80 350 | 367,80 | 350 | 4,839587 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 367,80 270 | 367,80 | 270 | 26,590538 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 367,80 436 | 367,80 | 436 | 18,542686 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 367,80 415 | 367,80 | 415 | 12,833061 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 367,80 360 | 367,80 | 360 | 2,120718 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 367,80 270 | 367,80 | 270 | 26,590538 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 367,80 390 | 367,80 | 390 | 6,035889 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 367,80 390 | 367,80 | 390 | 6,035889 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 367,80 360 | 367,80 | 360 | 2,120718 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 367,80 415 | 367,80 | 415 | 12,833061 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 367,80 475 | 367,80 | 475 | 29,146275 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 367,80 350 | 367,80 | 350 | 4,839587 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 367,80 390 | 367,80 | 390 | 6,035889 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 367,80 400 | 367,80 | 400 | 8,754758 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 367,80 400 | 367,80 | 400 | 8,754758 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 367,80 360 | 367,80 | 360 | 2,120718 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 367,80 350 | 367,80 | 350 | 4,839587 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 475 | 367,80 | 475 | 29,146275 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 367,80 350 | 367,80 | 350 | 4,839587 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 475 | 367,80 | 475 | 29,146275 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 367,80 295 | 367,80 | 295 | 19,793366 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 367,80 295 | 367,80 | 295 | 19,793366 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 367,80 350 | 367,80 | 350 | 4,839587 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 367,80 352 | 367,80 | 352 | 4,295813 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 367,80 400 | 367,80 | 400 | 8,754758 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 367,80 295 | 367,80 | 295 | 19,793366 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 367,80 270 | 367,80 | 270 | 26,590538 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 367,80 375 | 367,80 | 375 | 1,957586 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 367,80 315 | 367,80 | 315 | 14,355628 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 475 | 367,80 | 475 | 29,146275 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 367,80 353 | 367,80 | 353 | 4,023926 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 475 | 367,80 | 475 | 29,146275 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 367,80 290 | 367,80 | 290 | 21,1528 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 367,80 375 | 367,80 | 375 | 1,957586 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 367,80 391 | 367,80 | 391 | 6,307776 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 367,80 | 367,80 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 367,80 315 | 367,80 | 315 | 14,355628 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 367,80 400 | 367,80 | 400 | 8,754758 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 475 | 367,80 | 475 | 29,146275 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 367,80 | 367,80 | -- | DZ BANK |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 367,80 315 | 367,80 | 315 | 14,355628 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 367,80 315 | 367,80 | 315 | 14,355628 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 367,80 391 | 367,80 | 391 | 6,307776 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 367,80 290 | 367,80 | 290 | 21,1528 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 367,80 290 | 367,80 | 290 | 21,1528 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 367,80 315 | 367,80 | 315 | 14,355628 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 30.10.2025 0 Monate | 30.10.2025 | 0 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 24.10.2025 0 Monate | 24.10.2025 | 0 Monate | 367,80 290 | 367,80 | 290 | 21,1528 | JEFFERIES | ||
| Novo Nordisk AS | 22.10.2025 12 Monate | 22.10.2025 | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 20.10.2025 0 Monate | 20.10.2025 | 0 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 17.10.2025 12 Monate | 17.10.2025 | 12 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 16.10.2025 0 Monate | 16.10.2025 | 0 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 12 Monate | 10.10.2025 | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 0 Monate | 10.10.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.10.2025 0 Monate | 09.10.2025 | 0 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 06.10.2025 12 Monate | 06.10.2025 | 12 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 06.10.2025 12 Monate | 06.10.2025 | 12 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 03.10.2025 0 Monate | 03.10.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 30.09.2025 12 Monate | 30.09.2025 | 12 Monate | 367,80 392 | 367,80 | 392 | 6,579663 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.09.2025 12 Monate | 29.09.2025 | 12 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 22.09.2025 0 Monate | 22.09.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 18.09.2025 0 Monate | 18.09.2025 | 0 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 18.09.2025 12 Monate | 18.09.2025 | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 18.09.2025 12 Monate | 18.09.2025 | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 17.09.2025 0 Monate | 17.09.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 16.09.2025 0 Monate | 16.09.2025 | 0 Monate | 367,80 425 | 367,80 | 425 | 15,55193 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.09.2025 12 Monate | 15.09.2025 | 12 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 15.09.2025 0 Monate | 15.09.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 11.09.2025 12 Monate | 11.09.2025 | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.09.2025 0 Monate | 10.09.2025 | 0 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 10.09.2025 0 Monate | 10.09.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 08.09.2025 12 Monate | 08.09.2025 | 12 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 08.09.2025 12 Monate | 08.09.2025 | 12 Monate | 367,80 540 | 367,80 | 540 | 46,818923 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.09.2025 0 Monate | 05.09.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 03.09.2025 0 Monate | 03.09.2025 | 0 Monate | 367,80 500 | 367,80 | 500 | 35,943448 | JPMORGAN | ||
| Novo Nordisk AS | 01.09.2025 0 Monate | 01.09.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 29.08.2025 12 Monate | 29.08.2025 | 12 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 26.08.2025 12 Monate | 26.08.2025 | 12 Monate | 367,80 620 | 367,80 | 620 | 68,569875 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.08.2025 12 Monate | 21.08.2025 | 12 Monate | 367,80 600 | 367,80 | 600 | 63,132137 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 18.08.2025 0 Monate | 18.08.2025 | 0 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS | ||
| Novo Nordisk AS | 18.08.2025 12 Monate | 18.08.2025 | 12 Monate | 367,80 340 | 367,80 | 340 | 7,558456 | UBS |
News
Aktuell
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M